Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Cara R Baker"'
Autor:
Ricardo McEwen, James A. Gossage, Gincy George, Naami Mcaddy, J Zylstra, Jesper Lagergren, Nyree Griffin, R Bott, William R. C. Knight, Mieke Van Hemelrijck, Mark Kelly, Nick Maisey, Andrew Davies, Cara R. Baker
Publikováno v:
Acta Oncologica. 60:1629-1636
BACKGROUND Neoadjuvant chemotherapy is often used prior to surgical resection for oesophageal adenocarcinoma but remains ineffective in a high proportion of patients. The histological Mandard tumour regression grade is used to determine chemoresponse
Autor:
J Zylstra, Nick Maisey, Cara R. Baker, Daniel M. Foley, Jesper Lagergren, Mohamed Saad Aboul-Enein, William R. C. Knight, Elizabeth C Smyth, Mark Kelly, Andrew Davies, James A. Gossage, David Cunningham, Wahyu Wulaningsih, Dionysios Dellaportas, William H. Allum
Publikováno v:
Journal of Surgical Oncology. 124:1296-1305
BACKGROUND Most patients presenting with oesophageal cancer do so with advanced disease not suitable for surgery. However, there are examples of encouraging survival following surgery in highly selected patients who respond well to chemotherapy. METH
Autor:
Jonathan Moore, Michael Green, Mieke Van Hemelrijck, Harriet Deere, Richard PT Evans, Mona Elshafie, Anita Lavery, Andrew McGuigan, Rosalie Douglas, Damian Mcmanus, Joanne Horne, Robert Walker, Hira Mir, Monica Terlizzo, Sivesh K Kamarajah, Aida Santaolalla, Nick Maisey, Ailsa Lumsden, Sarah Ngan, Mark Kelly, Cara R Baker, Sacheen Kumar, Jesper Lagergren, William H Allum, James A Gossage, Ewan Griffiths, Heike I Grabsch, Richard C Turkington, Tim Underwood, Elizabeth Smyth, Rebecca Fitzgerald, David Cunningham, Andrew R Davies
Publikováno v:
Diseases of the Esophagus. 35
The prognostic benefit of primary tumour and lymph node (LN) downstaging after neoadjuvant chemotherapy for oesophageal adenocarcinoma (OAC) is well described. However, there is no robust evidence regarding the prognostic effect of pathological LN re
Autor:
Jonathan Moore, Manil Subesinghe, Aida Santaolalla, Michael Green, Harriet Deere, Mieke Van Hemelrijck, Jesper Lagergren, Sugama Chicklore, Nick Maisey, Mark Kelly, James A Gossage, Cara R Baker, Andrew R Davies
Publikováno v:
Diseases of the Esophagus. 35
2-deoxy-2[18F]fluoro-D-glucose positron emission tomography-computed tomography (FDG-PET-CT) is routinely used for staging of oesophageal cancer and has an emerging role in assessing response to neoadjuvant therapy. The primary aim of this study was
Autor:
Cara R. Baker, William R. C. Knight, Wahyu Wulaningsih, Andrew Davies, Mark Kelly, Nyree Griffin, James A. Gossage
Publikováno v:
Br J Cancer
Background A high Mandard score implies a non-response to chemotherapy in oesophageal adenocarcinoma. However, some patients exhibit tumour volume reduction and a nodal response despite a high score. This study examines survival and recurrence patter
Autor:
William R. C. Knight, Justin S. Waters, William H. Allum, R Bott, J Zylstra, David Cunningham, Nick Maisey, Michelle J. Wilkinson, Jesper Lagergren, James A. Gossage, Mark Kelly, Kerri Beckmann, Cara R. Baker, Elizabeth C Smyth, Andrew Davies, Mieke Van Hemelrijck
Publikováno v:
Acta Oncologica. 60:672-680
Background: The role of adjuvant therapy in patients with oesophagogastric adenocarcinoma treated by neoadjuvant chemotherapy (NAC) and surgery is contentious. In UK practice, surgical resection margin status is often used to classify patients into r
Autor:
Ben E. Byrne, James A. Gossage, Andrew R Davies, Joanna Taylor, Jason M Dunn, Annabelle White, Orla Evans, Jonathan L Moore, Cara R. Baker, Annie Coombes, Phillip H Pucher, Jesper Lagergren, Mark Kelly, Jervoise Andreyev, Sebastian Zeki
Purpose: Long-lasting symptoms and reductions in quality of life are common after oesophago-gastric surgery. Post-operative follow-up has traditionally focussed on tumour recurrence and survival, but there is a growing need to also identify and treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a01f0ecc84136b715702fbcfdbcf8dc6
https://doi.org/10.21203/rs.3.rs-1054245/v1
https://doi.org/10.21203/rs.3.rs-1054245/v1
Publikováno v:
Diseases of the Esophagus. 34
A high Mandard score corresponds to a non-response to chemotherapy in the primary tumour in oesophageal adenocarcinoma. However, some patients experience tumour volume reduction and a nodal downstaging despite a high score. This study compares surviv
Autor:
Arasteh Reyhani, Jason M Dunn, Aida Santaolalla, Janine Zylstra, Eliza Gimson, Mark Pennington, Cara R Baker, Mark Kelly, Mieke Van Hemelrijck, Jesper Lagergren, Sebastian S Zeki, James A Gossage, Andrew R Davies
Publikováno v:
Diseases of the Esophagus. 34
To assess the outcomes of patients with early esophageal cancer (EEC) and high-grade dysplasia (HGD) comparing esophagectomy, the historical treatment of choice, to endoscopic eradication therapy (EET). Methods Retrospective cohort study of consecuti
Autor:
James A. Gossage, Jesper Lagergren, Andrew Davies, Eliza Gimson, Aida Santaolalla, Jason M Dunn, Mark Kelly, J Zylstra, Cara R. Baker, Arasteh Reyhani, Mark Pennington, Sebastian Zeki, Mieke Van Hemelrijck
Publikováno v:
Diseases of the Esophagus. 35
Summary Background To assess the outcomes of patients with early esophageal cancer and high-grade dysplasia comparing esophagectomy, the historical treatment of choice, to endoscopic eradication therapy (EET). Methods Retrospective cohort study of co